Author

A. G. Jochemsen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1

Frequent Co-Authors

M. C. Gelmi· 2 shared M. J. Jager· 2 shared A. Alay· 1 shared A. C. O. Vertegaal· 1 shared A. F. A. S. Teunisse· 1 shared A. Groenewoud· 1 shared A. Teunisse· 1 shared C. Prunier· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. C. Gelmi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Comparative phosphoproteome analysis of primary and metastatic uveal melanoma cell lines

K. Glinkina, R. G. Prieto, A. F. A. S. Teunisse, M. C. Gelmi, M. J. Jager, A. C. O. Vertegaal, A. G. Jochemsen

The paper compares phosphoproteomes of primary and metastatic uveal melanoma cell lines to identify altered signaling pathways and potential drug targets.

bioRxiv · Dec 6, 2023 · PreprintCancer Biology

Patient-derived zebrafish xenograft models reveal ferroptosis as a fatal and druggable weakness in metastatic uveal melanoma

A. Groenewoud, J. Yin, M. C. Gelmi, S. Alsafadi, F. Nemati, D. Decaudin, S. Roman-Roman, H. Kalirai, S. E. Coupland, A. G. Jochemsen, M. J. Jager, E. Snaar-Jagalska

The paper develops a zebrafish xenograft model of metastatic uveal melanoma and identifies ferroptosis as a druggable vulnerability in tumors with BAP1 loss.

bioRxiv · Oct 26, 2021 · PreprintCancer Biology

Breast cancer dormancy is associated with a 4NG1 state and not senescence

C. Prunier, A. Alay, M. van Dijk, K. L. Ammerlaan, S. van Gelderen, D. L. Marvin, A. Teunisse, R. C. Slieker, K. Szuhai, A. G. Jochemsen, X. Sole, P. ten Dijke, L. Ritsma

The paper characterizes breast cancer dormancy in cell lines, showing D2.OR cells enter a 4NG1 state rather than senescence, and can be reversed.

bioRxiv · Nov 20, 2020Cell Biology